Tumor inflamatorio miofibroblástico pulmonar

Pinilla, Inmaculada; Herrero, Yolanda; Torres, Marisa; Nistal, Manuel; Pardo, Mercedes

doi:10.1016/s0033-8338(07)73718-9

Cited by 21 publications

(25 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several hypotheses have been proposed such as an auto-immune mechanism or infectious origin. Indeed, 30% of cases are closely related to recurrent respiratory infections which are caused by several microorganisms such as Mycoplasma, Nocardia, Actinomycetes, Epstein Barr and human herpes virus [3,4]. In the present case, the patient is a 45 year old male with history of cough and dyspnoea, with positive bronchial washings for PTB.…”

Section: Discussionmentioning

confidence: 78%

See 1 more Smart Citation

Inflammatory Myofibroblastic Tumor of Lung with Tuberculosis

Paramanandhan¹

2017

MOJCR

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 78%

“…It is most commonly seen in young adults though rare in patients above 60 years of age. The commonest presentation is cough, dyspnoea etc., there could be no underlying symptoms in most cases [3]. Complete surgical excision is the treatment of choice.…”

Section: Introductionmentioning

confidence: 99%

Inflammatory Myofibroblastic Tumor of Lung with Tuberculosis

Paramanandhan¹

2017

MOJCR

View full text Add to dashboard Cite

“…Inflammatory myofibroblastic tumor (IMT) is a rare benign tumor, accounting for 0.7% of all lung tumors [ 1 , 2 ]. First described by Brunn in 1939, it is an inflammatory, reactive, and nonneoplastic process characterized by unregulated growth of inflammatory cells [ 3 ].…”

Section: Introductionmentioning

confidence: 99%

“…The clinical and radiological manifestations are diverse and nonspecific. Diagnosis is difficult to establish without surgical resection [ 2 , 5 ]. Since inflammatory pseudotumor (IPT) is a benign disease which ambiguously presents with a tumor-like shadow having an irregular periphery on imaging, a diagnosis discriminating between IPT and malignant tumor is essential.…”

Section: Introductionmentioning

confidence: 99%

Inflammatory pseudotumour: A rare tumor of lung

Marwah

Bhutani

Dahiya

et al. 2018

Annals of Medicine and Surgery

View full text Add to dashboard Cite

Inflammatory pseudotumours of the lungs have rarely been reported. These have been described as a benign entity of unknown origin and are often locally invasive requiring extensive pulmonary resection. Complete resection is the key to prevent recurrence and the prognosis is excellent following surgery. We describe a patient with inflammatory pseudotumour of the lung. He was a middle aged man who presented with haemotysis and the chest X-ray and computerized tomography were indicative of a nonbenign lesion in the right upper lobe. Excision biopsy confirmed the diagnosis of inflammatory myofibroblastic pseudotumour of the lung. This is a rare inflammatory nonneoplastic condition commonly affecting children and young adults.

show abstract

“…2,3 Late stage patients are not the best candidates for curative surgery due to extent of the disease, comorbidities and poor cardio-respiratory function.PIMT is a rare benign tumor that constitutes 0.7% of all lung lesions. [4][5][6][7][8][9] Diagnosis through biopsy and radiologic exam is difficult due to its varying cell characteristic and images. Management of this rare disease is dependent on the type of tumor, extent of disease and general health status of the patient.…”

mentioning

confidence: 99%

Microwave Ablation in Managing Lung Cancer: A Case Report Article Sidebar

Saenghirunvattana¹,

Napairee²,

Geraplangsub³

2019

bkkmedj

View full text Add to dashboard Cite

Lung cancer recurrence and metastasis from other organs is now frequently observed. 1 For early stages, surgery remains the first choice of treatment but recent studies reported that 2-5% of non-small cell lung cancer (NSCLC) patients later develop metastasis or tumor recurrence. 2,3 Late stage patients are not the best candidates for curative surgery due to extent of the disease, comorbidities and poor cardio-respiratory function.PIMT is a rare benign tumor that constitutes 0.7% of all lung lesions. [4][5][6][7][8][9] Diagnosis through biopsy and radiologic exam is difficult due to its varying cell characteristic and images. Management of this rare disease is dependent on the type of tumor, extent of disease and general health status of the patient. 10 For treatment purposes and to prevent recurrences, complete resection is necessary. However, not all are valid candidates undergo surgery. 11There are other available treatment options both for early and late stages of lung cancer and inflammatory myofibroblastic tumor (IMT) that are minimally invasive. These include chemotherapy, target therapy, radio therapy and thermal ablation which are proven safe and effective management options. 1,[12][13][14][15] MWA therapy is a technology that is image-guided and uses high frequency microwave energy waves that produce tissue-heating effects to destruct solid tumors. It is less invasive, proven effective, preserves normal lung parenchyma and can enhance the efficacy of chemotherapy and/or external beam radiation. 16 The purpose of this study is to evaluate the safety and efficacy of MWA as an alternative treatment of lung tumors in different case scenarios. Case Reports Case # 1In October 2016, a 69-year-old female patient came for a routine check-up. She was asymptomatic, non-smoker and had no family history of tuberculosis or lung cancer. Her chest x-ray showed an ill-defined nodule at left upper lung, measuring about 4.0x4.2 cm, with diffuse nodular opacity in both lungs. Computed tomography (CT) of chest revealed multiple small nodules measuring 4 mm, 5 mm, and 6 mm at the right AbstractLung tumors are effectively managed through surgery. But for inoperable lung cancers such as in advanced stages, poor respiratory function and other diseases like pulmonary inflammatory myofibroblastic tumor (PIMT), minimal invasive techniques like percutaneous microwave ablation (MWA) therapy is the preferred treatment option. MWA is a curative alternative approach used to destroy malignant tumor cells with minimal normal tissue damage. This instrument uses high frequency microwave energy waves that produce tissue-heating effects to destruct solid tumors. The purpose of this case report is to illustrate how MWA effectively managed four various cases of lung cancer.

show abstract

Tumor inflamatorio miofibroblástico pulmonar

Cited by 21 publications

References 11 publications

Inflammatory Myofibroblastic Tumor of Lung with Tuberculosis

Inflammatory Myofibroblastic Tumor of Lung with Tuberculosis

Inflammatory pseudotumour: A rare tumor of lung

Microwave Ablation in Managing Lung Cancer: A Case Report Article Sidebar

Contact Info

Product

Resources

About